Taken together our findings have profound translational implications because we identified a new MITF/miR-579-3p regulatory network that impacts on melanoma proliferation, differentiation and drug resistance and whose targeting may provide a novel therapeutic strategy for BRAF-mutant melanomas. Here, MITF is linked to melanoma.